Jin Medical International
ZJYL
13 hedge funds and large institutions have $452K invested in Jin Medical International in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 7 closing their positions.
0.19% less ownership
Funds ownership: 0.64% → 0.45% (-0.19%)
24% less funds holding
Funds holding: 17 → 13 (-4)
39% less capital invested
Capital invested by funds: $747K → $452K (-$295K)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$99.1K |
| 2 |
VF
Virtu Financial
New York
|
+$10.3K |
| 3 |
HF
HRT Financial
New York
|
+$9.13K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.09K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$96.7K |
| 2 |
Goldman Sachs
New York
|
-$90K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$58.4K |
| 4 |
Millennium Management
New York
|
-$52.1K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$17.1K |
ZJYL Hedge Fund Activity: Q2 2025 in Review
13 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q2 2025, worth a combined $452K — down 39% from $747K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ZJYL and 3 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 3 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $99.1K. The largest seller was Invesco, exiting entirely with an estimated $96.7K sold.
- 13 institutional investors held Jin Medical International (ZJYL) as of Q2 2025, down from 17 in Q1 2025.
- Funds reported $452K of Jin Medical International stock for Q2 2025, down 39% quarter-over-quarter.
- 3 funds opened new Jin Medical International positions in Q2 2025 and 7 closed out, a net change of -4 holders.
- The largest Jin Medical International buyer in Q2 2025 was Citadel Advisors, an estimated $99.1K added.
- The largest Jin Medical International seller in Q2 2025 was Invesco, an estimated $96.7K sold.
Based on aggregated 13F filings for Q2 2025.